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determined by diminishing size of the aneurysm and
absence of endoleak. There is no indication on the evi-
dence available that this large group of patients may be
harboring unsuspected and potentially dangerous
microleaks. 
This report raises several questions. First, does the
entity of “microleak” exist? The angiograms in Figs 7 and
9 and the duplex ultrasound scan in Fig 8 are convincing.
The operative findings of bleeding through the endograft
in two patients are more questionable because thrombus
has to be manually removed to see the endograft and may
result in starting a bleeding point that did not previously
exist. On the other hand, it should be noted that the
authors would have been likely to note a jet of blood if
one existed, because they opened the aneurysm sac with-
out the application of any clamps in one patient and with
only one iliac clamp applied in the other. 
Are these microleaks iatrogenic? The authors have
considered this possibility, acknowledging that a single
small puff of contrast through an iliac limb in immediate
juxtaposition to the end hole of the catheter in one of the
two patients in whom a power injection was used may
have resulted from the injection itself. The technique of
balloon occlusion of an iliac limb and manual injection of
contrast through the balloon catheter after removal of the
guide wire as depicted in Fig 9 leaves little doubt as to the
genuine nature and site of the microleak, being well clear
of the gate area and distal anchor zone. It should also be
noted in patient C that microleaks were observed on
duplex scanning before any angiographic intervention. 
Is a microleak of any clinical significance? An increase
in the diameter of AAAs in three of the four patients
reported would suggest that the answer is yes. Another
way of establishing this would be to look at the effect of
treating microleaks in patients B and C where this was
attempted. In both cases secondary endografts were
placed within the limbs of the primary endograft at sites
where microleaks had been diagnosed. In patient B the
known endoleak persisted on follow-up CT. In patient C
the follow-up CT scan was inconclusive because contrast
media were seen in the aneurysm sac in the preinfusion
This report is important because it describes a failure
mode after endoluminal abdominal aortic aneurysm
(AAA) repair not previously recognized. This is a fabric
defect at the site of suture holes that results in a persistent
Type III endoleak. Extravasation of contrast at suture
points and between the interstices of the fabric has been
recognized since the introduction of the AneuRx device 5
years ago and has been referred to as porosity or Type IV
endoleak. This form of endoleak, however, usually seals
within days of implantation and is not seen on contrast
computed tomography (CT) at 1 month. The unique fea-
tures of the current report are that the endoleaks have per-
sisted for up to 21⁄2 years after operation and have been
associated with broken sutures. The Type III endoleaks in
this report must also be distinguished from previously
reported seam defects in Stentor (Mintec, LaCiotat,
France) prostheses and the chronic fabric wear against
metallic stents seen in Vanguard (Boston Scientific,
Natick, Mass) prostheses. 
The authors also describe a number of special maneu-
vers that allow the site of these small Type III endoleaks
to be identified. It has long been recognized that contrast
CT is an excellent method of detecting the presence of an
endoleak but is not always a reliable way of detecting the
site of an endoleak. The authors have rightly emphasized
that they are not describing previously unrecognized
endoleaks, but rather endoleaks that have been seen on
standard contrast CT without the exact site of origin being
identified. It is important for us all to understand this, to
avoid excessive and unwarranted imaging on large num-
bers of patients whose clinical course is satisfactory as
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run. There is no evidence that repairing a microleak will
cure an endoleak previously noted on conventional con-
trast CT or reverse the trend of aortic sac enlargement. 
This report also highlights a problem in the man-
agement of some patients undergoing endoluminal
AAA repair. This has arisen from patients being oper-
ated on in a specialist department of vascular surgery by
surgeons with expertise in endovascular repair and then
returned to “local” medical officers who acted on their
own interpretation of follow-up imaging rather than
that of the core laboratory. In fairness the core labora-
tory report may well have not been available.
Nevertheless, management by triumvirate is not in the
patients’ best interests. Patient A, for example, was var-
iously thought by the operating surgeons to have a
Type IV porosity endoleak and by the local medical
officers to have a Type II lumbar endoleak and a Type
I left limb endoleak that was treated with an extension
endograft. The core laboratory thought the patient had
a Type III endoleak at the junction of modular compo-
nents of the graft, plus a Type II lumbar endoleak,
whereas the operative findings demonstrated bleeding
from the right limb of the endograft. In situations such
as these, it would be preferable for the management of
the patient to remain in the hands of the original, expe-
rienced operating team. 
The major limitation of this report is the absence of
pathologic and scanning electron microscopy data on the
two explanted prostheses. Despite this deficiency the
authors have made a convincing case for the existence of
microleaks and the need to further investigate their signif-
icance. The techniques of “directed” angiography and
duplex scanning to identify these microleaks are useful and
merit further study with a controlled protocol in experi-
enced centers. It will be important to establish that treat-
ment of microleaks has a tangible benefit in the form of
reversing the trend of AAA enlargement to counter the
argument that they are incidental findings of no signifi-
cance in patients with conventional “macro” endoleaks. It
seems the techniques described would be most useful in
(1) patients with an enlarging aneurysm but no evidence of
endoleak and (2) patients with an enlarging aneurysm and
an endoleak whose site of origin has not been identified. 
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Please see the related article by Dr Jon S. Matsumura
et al on pages 190-7.
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